SCHEMBL844963

SCHEMBL844963

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)C3CCC3)cc2)cc1)[C@@H]1CCCN1C(=O)c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 8/20 0.47
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 3/20 0.42
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
ADRB2 P07550 1/20 0.42
HSD17B10 Q99714 1/20 0.42
TSHR P16473 1/20 0.41
PABPC1 P11940 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
GRM5 P41594 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL845048 0.93 DGAT1 (0.50) DGAT1SMN1; SMN2KDM4EALDH1A1RAB9A
SCHEMBL845255 0.86 CYP2C9 (0.47) ALDH1A1NPC1CYP2C9CYP2C19TSHR
SCHEMBL845250 0.84 HCRTR1 (0.46) DGAT1SMN1; SMN2KDM4EALDH1A1CYP2C9
SCHEMBL845935 0.84 PABPC1 (0.44) DGAT1SMN1; SMN2KDM4EALDH1A1CYP2C9
SCHEMBL845405 0.83 TRPV1 (0.46) DGAT1SMN1; SMN2KDM4ENPC1CYP2C9
SCHEMBL845234 0.83 RHOC (0.43) SMN1; SMN2ALDH1A1RAB9ANPC1CYP2C9
SCHEMBL845643 0.83 MAPK1 (0.50) DGAT1ALDH1A1RAB9ACYP2C9CYP2C19
SCHEMBL844884 0.82 HTT (0.48) ALDH1A1NPC1CYP2C9CYP2C19TSHR
SCHEMBL13272265 0.80 DGAT1 (0.41) DGAT1SMN1; SMN2KDM4EALDH1A1CYP2C9
SCHEMBL845686 0.79 HSD11B1 (0.43) DGAT1SMN1; SMN2ALDH1A1RAB9ACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed